Yarrow Bioscience, Inc. (YARW)
NASDAQ: YARW · Real-Time Price · USD
15.60
+2.00 (14.71%)
At close: Nov 6, 2026, 4:00 PM EST
15.54
-0.06 (-0.38%)
After-hours: Nov 6, 2026, 7:30 PM EST

Yarrow Bioscience Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Yarrow Bioscience stock has a consensus rating of "Strong Buy" and an average price target of $58. The average 1-year stock price forecast is 271.79% higher than the current stock price, while the lowest is $56 (+258.97%) and the highest is $60 (+284.62%).

Price Target: $58 (+271.79%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$56$58$58$60
Change+258.97%+271.79%+271.79%+284.62%
* Price targets were last updated on Aug 13, 2026.

Analyst Ratings

The average analyst rating for Yarrow Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJul '26Aug '26Nov '26
Strong Buy134
Buy000
Hold000
Sell000
Strong Sell000
Total134

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
LifeSci Capital
LifeSci Capital
Buy
Maintains
$56
BuyMaintains$56+258.97%Aug 13, 2026
BTIG
BTIG
Buy
Initiates
$58
BuyInitiates$58+271.79%Aug 3, 2026
TD Cowen
TD Cowen
Buy
Initiates
n/a
BuyInitiatesn/an/aJul 28, 2026

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.45
EPS Next Year
-1.65
from -1.45
Fiscal YearFY 2025FY 2026
Period EndingDec 31, 2025Dec 31, 2026
Revenue
--
Operating Income
-3.98M-32.80M
Net Income
-283.98M-32.50M
EPS
--1.45
Free Cash Flow
--33.00M
No. Analysts
-3
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-1.45
Avg-1.45
Low-1.45

EPS Growth

EPS Growth20272028
High-
Avg-
Low-